ENTASIS THERAPEUTICS HLDGS I's ticker is ETTX and the CUSIP is 293614103. A total of 19 filers reported holding ENTASIS THERAPEUTICS HLDGS I in Q4 2019. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2021 | $120,000 | +76.5% | 55,813 | +172.0% | 0.00% | – |
| Q3 2021 | $68,000 | -19.0% | 20,516 | -35.5% | 0.00% | – |
| Q2 2021 | $84,000 | +425.0% | 31,793 | +296.0% | 0.00% | – |
| Q3 2020 | $16,000 | +77.8% | 8,029 | +175.6% | 0.00% | – |
| Q2 2020 | $9,000 | +12.5% | 2,913 | 0.0% | 0.00% | – |
| Q1 2020 | $8,000 | -42.9% | 2,913 | 0.0% | 0.00% | – |
| Q4 2019 | $14,000 | -17.6% | 2,913 | 0.0% | 0.00% | – |
| Q3 2019 | $17,000 | -10.5% | 2,913 | 0.0% | 0.00% | – |
| Q2 2019 | $19,000 | – | 2,913 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|